Financial Results

H1 2026 Results

Results for H1 2026 were published on July 30, 2026.

The recording of Ipsen’s H1 2026 Results Call is now available on demand.

Watch the recording

Financial Results

Showing: 1 – 5 of 34

• Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance
  Read more

4 related documents/links

• H1 2026 - Results Announcement (707.30 KB)
  • H1 2026 - Results Highlights(191.92 KB)
  • H1 2026 - Investor Presentation(1.93 MB)
  • [H1 2026 - Results Webcast Replay

23 April 2026

• Ipsen delivers strong sales in the first quarter of 2026 and confirms its full-year guidance
  Read more

4 related documents/links

• Ipsen Q1 2026 Press Release (251.12 KB)
  • Ipsen Q1 2026 Highlights(404.22 KB)
  • Ipsen Q1 2026 Investor presentation(598.03 KB)

12 February 2026

• Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
  Read more

4 related documents/links

• FY 2025 - Results announcement(676.79 KB)
  • FY 2025 - Highlights(340.30 KB)
  • FY 2025 - Presentation (1.44 MB)

22 October 2025

• Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
  Read more

4 related documents/links

• Ipsen – YTD 2025 results announcement (370.49 KB)
  • Ipsen – YTD 2025 results highlights(312.14 KB)
  • Ipsen – YTD 2025 investor presentation(1.11 MB)

31 July 2025

• Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance
  Read more

4 related documents/links

• H1 2025 - results announcement(1.01 MB)
  • H1 2025 - results highlights(281.93 KB)
  • H1 2025 - results presentation (865.60 KB)
  • [H1 2025 - Results webcast replay